Posts for Ticker ‘QSII’

Top Analyst Downgrades (BCS, CBY, CBS, LFC, CHL, DBD, ELX, NCR, PHG, QSII)

These are some of the top pre-market analyst downgrades and negative analyst calls we have seen from Wall Street firms this Monday morning:

Barclays (BCS) Cut to Sell at Societe Generale.
Cadbury (CBY) Cut to Underweight at JPMorgan.
CBS (CBS) Cut to Sell at UBS.
China Life Insurance Co. Ltd. (LFC) Cut to Neutral at UBS.
China Mobile (CHL) Cut to Neutral at UBS.
Diebold (DBD) Cut to Neutral at Baird.
Emulex (ELX) Cut to Sector Perform at RBC.
NCR (NCR) Cut to Neutral at Baird.
Philips (PHG) Cut to Sell at Societe Generale.
Quality Systems (QSII) Cut to Sell at UBS.

JON C. OGG

Posted on: March 30, 2009 – 6:24 am in Analyst Calls, , , , , , , , , ,

Top Analyst Upgrades (AKAM, BSX, CLX, CVA, ESRX, MCRS, PRXL, PFE, QSII, SGMS)

Money_stack_picThese are some of the top analyst upgrades and positive calls we are seeing this Monday morning:

  • Akamai (AKAM) Raised to Buy at Merriman Curhan Ford.
  • Boston Scientific (BSX) Raised to Overweight at Thomas Weisel.
  • Clorox (CLX) Raised to Buy at Goldman Sachs.
  • Covanta (CVA) Raised to Overweight at JPMorgan.
  • Express Scripts (ESRX) Raised to Buy at Goldman Sachs.
  • Micros Systems (MCRS) Started as Outperform at Oppenheimer.
  • PAREXEL (PRXL) Raised to Outperform at Wachovia.
  • Pfizer (PFE) Raised to Outperform at Credit Suisse.
  • Quality Systems (QSII) Raised to Buy at Piper Jaffray.
  • Scientific Games (SGMS) Raised to Buy at Goldman Sachs.

Jon C. Ogg
February 2, 2009

Posted on: February 2, 2009 – 7:48 am in Analyst Calls, , , , , , , , , ,

Top Pre-Market Analyst Downgrades (BGFV, CME, QSII, TUP, SKS)

These are some of the negative calls and downgrades we have seen this Wednesday morning:

  • Big 5 Sporting Goods (BGFV) cut to sell at UBS.
  • CME Group (CME) cut to market perform at KBW.
  • Quality Systems (QSII) cut to hold at Jefferies.
  • Tupperware (TUP) cut to neutral at JPMorgan.
  • Saks (SKS) started as underweight at JPMorgan.

Jon C. Ogg
September 17, 2008

Posted on: September 17, 2008 – 7:02 am in Analyst Calls, , , , ,

Top Pre-Market Analyst Downgrades (DHR, LEH, QSII, SONC, SPWR)

There are surprisingly few analyst calls today, but these are some of the top calls we have seen as downgrades with more than two hours to the market open:

  • Danaher (DHR) Cut to Hold at Deutsche Bank.
  • Lehman Brothers (LEH) has been dropped from coverage by Morgan Stanley.
  • Quality Systems (QSII) Cut to Neutral at Piper Jaffray.
  • Sonic (SONC) Started as Neutral at Goldman Sachs.
  • Sunpower (SPWR) Started as Sell at Societe Generale.

Jon C. Ogg
September 12, 2008

Posted on: September 12, 2008 – 6:26 am in Analyst Calls, , , , ,

Quality Systems Free From SEC Inquiry (QSII)

Quality Systems, Inc. (NASDAQ:QSII) has issued a release stating that it received a letter dated November 19, 2007, from the Securities and Exchange Commission (L.A. regional office) that informed CFO Paul Holt that the SEC has completed its previously disclosed investigation of trading activities in Quality Systems’ securities.  The SEC does not intend to recommend any enforcement action concerning such activities to the Commission.

Quality Systems already released its earnings back on October 31, and shares have lost roughly 17% since then. While there have not been any trades pre-market, shares are indicated slightly higher than yesterday’s $29.19 close.  Its 52-week trading range is $26.08 to $45.44.

Jon C. Ogg
November 20, 2007

Posted on: November 20, 2007 – 9:23 am in Healthcare, SEC, Software,

Cramer’s Overlooked Medical Billing Solutions IPO (ATHN, MDRX, QSII)

athenahealth (NASDAQ:ATHN) is a Web 2.0 version of medical billing, and it is like Allscripts Healthcare Solutions (NASDAQ:MDRX) and Quality Systems Inc. (NASDAQ:QSII).  He likes that the company has very high loyalty and renewal rates and this is a subscription services and this currently has $2 Billion in physician revenue under management that it gets a cut of.  He thinks it can earn $0.74 next year and even with the premium forward earnings multiples that it is actually cheap on a comparable basis to its growth.

Is this really an overlooked IPO?  No.  It came public at $18.00 and closed at $34.07.  He thinks this could go to $40.00 on its own, but also thinks a larger company could acquire it.  He also believes this will get positive analyst coverage soon.  This one ran so much that you cannot think this was overlooked at all.  This may not be that well known to the public, but traders have been playing this one over the last ten trading sessions since its IPO.  Shares rose 8% to $36.80 in after-hours on Cramer’s feature.

Jon C. Ogg
October 3, 2007

Posted on: October 3, 2007 – 5:31 pm in Cramer, IPOs, Medical, , , , ,